What happened Director James Healy bought 969,480 shares of Rapport Therapeutics, Inc. (NASDAQ: RAPP) at $21.00 each on Oct. 28, for $20.36 million. The shares were bought through four fund vehicles over which he may be deemed to share voting and dispositive power. Sofinnova Venture Partners XI, L.P. took 952,380 of the shares and now […]

Rapport Therapeutics, Inc. (NASDAQ:RAPP – Get Free Report) shares shot up 7.8% on Thursday. The company traded as high as $23.65 and last traded at $24.26. Approximately 223,703 shares changed hands during mid-day trading, a decline of 49% from the average session volume of 440,998 shares. The stock had previously closed at $22.50. Wall Street […]

Rapport Therapeutics, Inc. (NASDAQ:RAPP – Get Free Report) CEO Abraham Ceesay sold 2,210 shares of the business’s stock in a transaction dated Wednesday, October 21st. The shares were sold at an average price of $29.16, for a total transaction of $64,443.60. Following the completion of the transaction, the chief executive officer owned 450,035 shares in […]